Back

Optimized concomitant rhythm and ischemia management in patients with atrial fibrillation and coronary artery disease

12 April 2026 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Risk factor management in atrial fibrillation Rhythm Control, Catheter Ablation EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Jannis Dickow

Asklepios St. Georg Clinic, Hamburg (Germany)

5 More presentations in this session

Presentation thumbnail
Association of cognitive impairment with dyslipidemia in patients with atrial fibrillation: preliminary results from a prospective registry
Doctor S. Mohanty (Austin, US)
Abstract Slides Video
Presentation thumbnail
Change in sleep apnea parameters in patients with atrial fibrillation undergoing pulmonary vein isolation: interim analysis of the AAHIi study
Doctor P. Basiukiewicz (Grodzisk Mazowiecki, PL)
Abstract Slides Video
Presentation thumbnail
SGLT2 inhibitors and the risk of atrial fibrillation recurrence within one year after radiofrequency ablation
Doctor M. Velescu (Cluj Napoca, RO)
Abstract Slides Video
Presentation thumbnail
Improvement in the severity of sleep disordered breathing three months after pulmonary vein isolation in patients with persistent atrial fibrillation
Assistant Professor Y. Naruse (Hamamatsu, JP)
Abstract Slides Video
Presentation thumbnail
Impact of mobile health-detected airflow obstruction on periprocedural symptom severity and quality of life in patients with atrial fibrillation undergoing first-time ablation.
Ms K. Ignaczak (Warsaw, PL)
Abstract Slides Video

Access the full session

Session thumbnail
Risk factor management in atrial fibrillation

The Event

Event poster

EHRA 2026

12 April - 14 April 2026
You may be interested in
thumbnail
Congress Session
Registries on atrial fibrillation and sudden death
thumbnail
Congress Presentation
Cardiovascular hospitalizations in patients undergoing atrial tachycardia rhythm control
thumbnail
Congress Session
Catheter ablation in atrial fibrillation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources